|
VKTX Viking Therapeutics Inc 1607678 |
| Balance Sheet |
|
Current Assets
|
907,216,000 |
|
Assets
|
908,321,000 |
|
Current Liabilities
|
27,413,000 |
|
Liabilities
|
28,043,000 |
|
Equity
|
880,278,000 |
|
Shares Out
|
110,796,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-87,790,000 |
|
Investing Cash Flow
|
-553,366,000 |
| Market Analysis |
Market Cap
|
6,964,006,342 |
|
Price
|
29.71 |
|
BVPS
|
7.95 |
|
PB
|
3.75 |
|
EPS
|
-0.94 |
|
PS
|
0.73 |
|
FCF
|
-641,156,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VKTX documents filed with the SEC.
VKTX Filings
Clear
